FONR

Fonar Corporation

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

0.00%

FONR price

Fonar

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment FONR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals FONR

Valuation

P/E

Sector -0.74

Industry 5.42

P/BV

Sector 1.97

Industry 3.88

P/Revenue (PSR)

Sector 1.74

Industry 3.79

EV/EBITDA

Sector -8.33

Industry 25.54

EV/EBIT

Sector -14.02

Industry -11.16

P/EBITDA

Sector -44.73

Industry 9.99

P/EBIT

Sector -45.73

Industry -8.23

P/Total Assets

Sector 0.91

Industry 1.49

P/Net Current Assets

Sector -25.37

Industry -4.37

P/Working Capital

Sector -5.79

Industry 5.81

EPS

Sector -0.83

Industry -0.21

BVPS

Sector 3.91

Industry 6.45

Efficiency

Gross Margin

Sector 45.33%

Industry 54.34%

EBITDA Margin

Sector -312.56%

Industry -12.07%

EBIT Margin

Sector -198.10%

Industry -24.61%

Operating Margin

Sector -23.11%

Industry -3.00%

Net Profit Margins

Sector -28.02%

Industry -7.67%

Asset Turnover

Sector 0.13

Industry 0.12

Profitability

ROE

Sector -29.59%

Industry -24.14%

ROA

Sector -28.62%

Industry -6.01%

ROIC

Sector -521.05%

Industry -16.46%

Dividends

Dividend yield

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.85

Industry 2.52

Net Debt / EBITDA

Sector -1.07

Industry 10.38

Net Debt / EBIT

Sector -1.09

Industry 6.00

Net Debt / Equity

Sector -0.34

Industry 0.01

Gross Debt / Equity

Sector 0.14

Industry 0.55

Equity/Assets

Sector 0.43

Industry 0.46

Liabilities/Assets

Sector 0.48

Industry 0.53

Growth

5Y Revenue CAGR

Sector -

Industry -

5Y Earnings CAGR

Sector -

Industry -

FAIR VALUE OF Fonar ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$28.91

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals FONR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
FONR Fonar Corporation	$0.00	-100.00%	0.00%	-	-	4.63%	7.85%
ISRG Intuitive Surgical Inc.	$376.05	-21.02%	0.00%	42.99	7.38	17.15%	28.45%
ABT Abbott Laboratories	$116.78	-9.91%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$93.36	4.78%	3.08%	24.65	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$49.36	-53.51%	0.00%	18.39	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$92.53	-22.80%	0.00%	21.76	6.37	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$555.84	-13.90%	0.00%	38.42	27.15	70.67%	25.03%
RMD ResMed Inc.	$232.29	-19.91%	1.03%	22.16	5.13	23.13%	26.94%
COHR Coherent Inc.	$276.10	207.12%	0.00%	69.45	4.98	7.16%	11.31%
PHG Koninklijke Philips NV	$27.56	1.06%	3.68%	20.32	1.99	9.80%	6.30%
SYK Stryker Corp.	$329.98	-15.23%	1.05%	34.02	5.29	15.55%	14.43%
INMD InMode Ltd.	$15.08	1.82%	0.00%	11.48	1.41	12.32%	20.69%
DXCM DexCom Inc.	$92.09	11.94%	0.00%	34.96	13.33	38.14%	20.12%
EW Edwards Lifesciences Corp.	$90.35	10.41%	0.00%	51.52	4.83	9.37%	15.43%
BDX Becton Dickinson and Company	$191.57	-1.14%	2.21%	55.53	2.14	3.85%	4.05%
ALGN Align Technology Inc.	$160.36	7.21%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.99	22.79%	1.43%	49.03	11.11	22.66%	26.71%
SNN Smith & Nephew PLC	$29.70	-18.11%	2.66%	10.95	2.38	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

FONR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/17/1999	03/30/1999	0.19000000
Dividends	12/15/1998	12/28/1998	0.19000000
Dividends	09/14/1998	09/25/1998	0.19000000
Dividends	05/12/1998	05/26/1998	0.57000000

ABOUT Fonar

Fonar Corporation

Average Investor10 user rating

4.0 (3 people)

United States

48 years

Founded: 1978

1981

Time since IPO - 45 years

424

Employees

Fonar Corporation (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $178.57 million.

The company employs approximately 424 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Fonar Corporation reported $105.34 million in revenue, generating net income of $8.27 million.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker FONR.

Market cap

Net worth

$178.57 million

$178,570,000.00

Assets

$219.22 million

$219,222,000.00

Total Shares Outstanding

6.30 million

6,296,000

Average Daily Trading Volume

$61.78 Thousand

$61,778.00

Sector

Health

Industry

Medical Supplies and Equipment

FONR

FONR revenue and profits

Financial Results FONR

DRAG THE FRAME TO SEE MORE DATA

FONR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.09 34,69% (12M)

P/E

24.36

2.86%

ROE

6.12%

P/BV

1.49

CI - Cigna

$278.76 --5,87% (12M)

P/E

10.67

2.22%

ROE

16.04%

P/BV

1.71

CNC - Centene

$65.86 123,94% (12M)

P/E

-6.26

0.00%

ROE

-22.51%

P/BV

1.41

HUM - Humana

$382.82 29,66% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$45.64 --7,62% (12M)

P/E

7.49

3.84%

ROE

18.43%

P/BV

1.38

LLY - Eli Lilly

$1,242.93 70,31% (12M)

P/E

42.15

0.51%

ROE

78.84%

P/BV

33.23

HCA - HCA Healthcare

$430.50 7,00% (12M)

P/E

13.87

0.70%

ROE

-213.15%

P/BV

-29.56

NVS - Novartis

$158.24 27,04% (12M)

P/E

23.74

1.95%

ROE

30.41%

P/BV

7.22